Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Royce & Associates LP

Royce & Associates LP reduced its holdings in Exponent, Inc. (NASDAQ:EXPOFree Report) by 10.3% during the 3rd quarter, Holdings Channel reports. The fund owned 187,726 shares of the business services provider’s stock after selling 21,442 shares during the quarter. Royce & Associates LP’s holdings in Exponent were worth $21,641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in EXPO. Quarry LP acquired a new stake in Exponent in the 2nd quarter valued at approximately $25,000. GAMMA Investing LLC increased its position in Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after acquiring an additional 153 shares during the period. Whittier Trust Co. of Nevada Inc. increased its position in Exponent by 166.5% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after acquiring an additional 323 shares during the period. USA Financial Formulas acquired a new stake in Exponent in the 3rd quarter valued at approximately $60,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in Exponent by 70.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after acquiring an additional 361 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Truist Financial restated a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Check Out Our Latest Stock Analysis on EXPO

Exponent Stock Performance

Shares of EXPO stock opened at $97.40 on Friday. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75. The stock has a market cap of $4.94 billion, a PE ratio of 47.05 and a beta of 0.69. The business’s fifty day moving average is $107.23 and its 200-day moving average is $101.97.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.15%. The ex-dividend date is Friday, December 6th. Exponent’s dividend payout ratio (DPR) is presently 54.11%.

Insider Activity

In other news, Director Paul R. Johnston sold 7,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $103.83, for a total transaction of $726,810.00. Following the completion of the sale, the director now directly owns 80,742 shares of the company’s stock, valued at $8,383,441.86. This trade represents a 7.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Carol Lindstrom sold 1,039 shares of the firm’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now directly owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This represents a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,039 shares of company stock worth $2,291,286. 2.10% of the stock is owned by company insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.